Spurring innovation in the biotech industry will save lives By John Crowley Key Points Crowley emphasized that maintaining U.S. leadership in biotechnology is vital to both public health and national security, especially amid China’s rapid rise in ... Read more Colorado drug affordability board faces suit over price fixing By HPN Staff Key Points For the second time, Amgen has sued Colorado’s Prescription Drug Affordability Review Board over its decision to cap the price of Enbrel, an autoimmune drug, at $60... Read more Ivermectin debate reignites as more states eye over-the-counter sales Key Points Florida and Ohio are considering bills to let pharmacies sell ivermectin without a prescription, joining at least 16 states exploring or enacting similar measures—five of which (Idaho,... Read more Colorado drug price cap raises concerns over access and innovation By HPN Staff Key Points Colorado became the first state to set a price cap on a specific prescription drug — limiting the cost of Enbrel, a rheumatoid arthritis treatment, to $600 per 50-m... Read more Researchers sound alarm on spike in drug-resistant ‘nightmare bacteria’ By HPN Staff Key Points Infections from NDM-producing carbapenem-resistant Enterobacterales jumped by over 460 % in recent years — a startling increase in strains resistant to almost all ... Read more Facing backlash, health insurers to curb use of prior authorization By HPN Staff Key Points U.S. health insurers, under pressure from policymakers, will scale back prior authorization requirements by 2026, easing delays that frustrate... Read more Stem cell therapy shows promise in treating lifelong disease By HPN Staff Key Points In a trial of 12 patients with type 1 diabetes, 10 were cured and 2 saw major improvement using the stem cell therapy Zimislecel. T... Read more Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more Pharma advances non-opioid pain drugs By HPN Staff The American pharmaceutical industry has been making significant progress in developing medications that can treat severe pain as effectively as opioids without the risk of addic... Read more Feds eye tighter restrictions on pharma ads By HPN Staff The Trump administration, led by Secretary of Health and Human Services Robert F. Kennedy Jr., is considering proposals to impose restrictions on pharmaceutical advertisements. ... Read more 1 2 Subscribe to Pharma MOST VIEWED 1 Ohio bill among several in the nation seeking to expand the role of optometrists 2 Stop spending Medicaid money on ineffective programs 3 Ivermectin debate reignites as more states eye over-the-counter sales 4 Bill seeks to protect the data gained from health-tracking wearables DONATE
Colorado drug affordability board faces suit over price fixing By HPN Staff Key Points For the second time, Amgen has sued Colorado’s Prescription Drug Affordability Review Board over its decision to cap the price of Enbrel, an autoimmune drug, at $60... Read more Ivermectin debate reignites as more states eye over-the-counter sales Key Points Florida and Ohio are considering bills to let pharmacies sell ivermectin without a prescription, joining at least 16 states exploring or enacting similar measures—five of which (Idaho,... Read more Colorado drug price cap raises concerns over access and innovation By HPN Staff Key Points Colorado became the first state to set a price cap on a specific prescription drug — limiting the cost of Enbrel, a rheumatoid arthritis treatment, to $600 per 50-m... Read more Researchers sound alarm on spike in drug-resistant ‘nightmare bacteria’ By HPN Staff Key Points Infections from NDM-producing carbapenem-resistant Enterobacterales jumped by over 460 % in recent years — a startling increase in strains resistant to almost all ... Read more Facing backlash, health insurers to curb use of prior authorization By HPN Staff Key Points U.S. health insurers, under pressure from policymakers, will scale back prior authorization requirements by 2026, easing delays that frustrate... Read more Stem cell therapy shows promise in treating lifelong disease By HPN Staff Key Points In a trial of 12 patients with type 1 diabetes, 10 were cured and 2 saw major improvement using the stem cell therapy Zimislecel. T... Read more Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more Pharma advances non-opioid pain drugs By HPN Staff The American pharmaceutical industry has been making significant progress in developing medications that can treat severe pain as effectively as opioids without the risk of addic... Read more Feds eye tighter restrictions on pharma ads By HPN Staff The Trump administration, led by Secretary of Health and Human Services Robert F. Kennedy Jr., is considering proposals to impose restrictions on pharmaceutical advertisements. ... Read more 1 2 Subscribe to Pharma MOST VIEWED 1 Ohio bill among several in the nation seeking to expand the role of optometrists 2 Stop spending Medicaid money on ineffective programs 3 Ivermectin debate reignites as more states eye over-the-counter sales 4 Bill seeks to protect the data gained from health-tracking wearables DONATE
Ivermectin debate reignites as more states eye over-the-counter sales Key Points Florida and Ohio are considering bills to let pharmacies sell ivermectin without a prescription, joining at least 16 states exploring or enacting similar measures—five of which (Idaho,... Read more Colorado drug price cap raises concerns over access and innovation By HPN Staff Key Points Colorado became the first state to set a price cap on a specific prescription drug — limiting the cost of Enbrel, a rheumatoid arthritis treatment, to $600 per 50-m... Read more Researchers sound alarm on spike in drug-resistant ‘nightmare bacteria’ By HPN Staff Key Points Infections from NDM-producing carbapenem-resistant Enterobacterales jumped by over 460 % in recent years — a startling increase in strains resistant to almost all ... Read more Facing backlash, health insurers to curb use of prior authorization By HPN Staff Key Points U.S. health insurers, under pressure from policymakers, will scale back prior authorization requirements by 2026, easing delays that frustrate... Read more Stem cell therapy shows promise in treating lifelong disease By HPN Staff Key Points In a trial of 12 patients with type 1 diabetes, 10 were cured and 2 saw major improvement using the stem cell therapy Zimislecel. T... Read more Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more Pharma advances non-opioid pain drugs By HPN Staff The American pharmaceutical industry has been making significant progress in developing medications that can treat severe pain as effectively as opioids without the risk of addic... Read more Feds eye tighter restrictions on pharma ads By HPN Staff The Trump administration, led by Secretary of Health and Human Services Robert F. Kennedy Jr., is considering proposals to impose restrictions on pharmaceutical advertisements. ... Read more 1 2 Subscribe to Pharma MOST VIEWED 1 Ohio bill among several in the nation seeking to expand the role of optometrists 2 Stop spending Medicaid money on ineffective programs 3 Ivermectin debate reignites as more states eye over-the-counter sales 4 Bill seeks to protect the data gained from health-tracking wearables DONATE
Colorado drug price cap raises concerns over access and innovation By HPN Staff Key Points Colorado became the first state to set a price cap on a specific prescription drug — limiting the cost of Enbrel, a rheumatoid arthritis treatment, to $600 per 50-m... Read more Researchers sound alarm on spike in drug-resistant ‘nightmare bacteria’ By HPN Staff Key Points Infections from NDM-producing carbapenem-resistant Enterobacterales jumped by over 460 % in recent years — a startling increase in strains resistant to almost all ... Read more Facing backlash, health insurers to curb use of prior authorization By HPN Staff Key Points U.S. health insurers, under pressure from policymakers, will scale back prior authorization requirements by 2026, easing delays that frustrate... Read more Stem cell therapy shows promise in treating lifelong disease By HPN Staff Key Points In a trial of 12 patients with type 1 diabetes, 10 were cured and 2 saw major improvement using the stem cell therapy Zimislecel. T... Read more Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more Pharma advances non-opioid pain drugs By HPN Staff The American pharmaceutical industry has been making significant progress in developing medications that can treat severe pain as effectively as opioids without the risk of addic... Read more Feds eye tighter restrictions on pharma ads By HPN Staff The Trump administration, led by Secretary of Health and Human Services Robert F. Kennedy Jr., is considering proposals to impose restrictions on pharmaceutical advertisements. ... Read more 1 2 Subscribe to Pharma
Researchers sound alarm on spike in drug-resistant ‘nightmare bacteria’ By HPN Staff Key Points Infections from NDM-producing carbapenem-resistant Enterobacterales jumped by over 460 % in recent years — a startling increase in strains resistant to almost all ... Read more Facing backlash, health insurers to curb use of prior authorization By HPN Staff Key Points U.S. health insurers, under pressure from policymakers, will scale back prior authorization requirements by 2026, easing delays that frustrate... Read more Stem cell therapy shows promise in treating lifelong disease By HPN Staff Key Points In a trial of 12 patients with type 1 diabetes, 10 were cured and 2 saw major improvement using the stem cell therapy Zimislecel. T... Read more Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more Pharma advances non-opioid pain drugs By HPN Staff The American pharmaceutical industry has been making significant progress in developing medications that can treat severe pain as effectively as opioids without the risk of addic... Read more Feds eye tighter restrictions on pharma ads By HPN Staff The Trump administration, led by Secretary of Health and Human Services Robert F. Kennedy Jr., is considering proposals to impose restrictions on pharmaceutical advertisements. ... Read more 1 2 Subscribe to Pharma
Facing backlash, health insurers to curb use of prior authorization By HPN Staff Key Points U.S. health insurers, under pressure from policymakers, will scale back prior authorization requirements by 2026, easing delays that frustrate... Read more Stem cell therapy shows promise in treating lifelong disease By HPN Staff Key Points In a trial of 12 patients with type 1 diabetes, 10 were cured and 2 saw major improvement using the stem cell therapy Zimislecel. T... Read more Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more Pharma advances non-opioid pain drugs By HPN Staff The American pharmaceutical industry has been making significant progress in developing medications that can treat severe pain as effectively as opioids without the risk of addic... Read more Feds eye tighter restrictions on pharma ads By HPN Staff The Trump administration, led by Secretary of Health and Human Services Robert F. Kennedy Jr., is considering proposals to impose restrictions on pharmaceutical advertisements. ... Read more 1 2 Subscribe to Pharma
Stem cell therapy shows promise in treating lifelong disease By HPN Staff Key Points In a trial of 12 patients with type 1 diabetes, 10 were cured and 2 saw major improvement using the stem cell therapy Zimislecel. T... Read more Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more Pharma advances non-opioid pain drugs By HPN Staff The American pharmaceutical industry has been making significant progress in developing medications that can treat severe pain as effectively as opioids without the risk of addic... Read more Feds eye tighter restrictions on pharma ads By HPN Staff The Trump administration, led by Secretary of Health and Human Services Robert F. Kennedy Jr., is considering proposals to impose restrictions on pharmaceutical advertisements. ... Read more 1 2 Subscribe to Pharma
Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more Pharma advances non-opioid pain drugs By HPN Staff The American pharmaceutical industry has been making significant progress in developing medications that can treat severe pain as effectively as opioids without the risk of addic... Read more Feds eye tighter restrictions on pharma ads By HPN Staff The Trump administration, led by Secretary of Health and Human Services Robert F. Kennedy Jr., is considering proposals to impose restrictions on pharmaceutical advertisements. ... Read more 1 2 Subscribe to Pharma
Pharma advances non-opioid pain drugs By HPN Staff The American pharmaceutical industry has been making significant progress in developing medications that can treat severe pain as effectively as opioids without the risk of addic... Read more Feds eye tighter restrictions on pharma ads By HPN Staff The Trump administration, led by Secretary of Health and Human Services Robert F. Kennedy Jr., is considering proposals to impose restrictions on pharmaceutical advertisements. ... Read more 1 2 Subscribe to Pharma
Feds eye tighter restrictions on pharma ads By HPN Staff The Trump administration, led by Secretary of Health and Human Services Robert F. Kennedy Jr., is considering proposals to impose restrictions on pharmaceutical advertisements. ... Read more 1 2 Subscribe to Pharma
